Cheng-Ho Chung

This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Alphala Co., Ltd.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cheng-Ho Chung. Retrieved from https://idiyas.com/inventor/cheng-ho-chung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 4 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

4 out of 4

Alphala Co., Ltd.

patents

Years Active: 2021-2025

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12358881 - Processes for producing amide compounds, and their crystalline and salt form (2025-07-15),

2. 11384060 - Amide compounds and use thereof (2022-07-12),

3. 11174253 - Compound and pharmaceutical composition containing the same (2021-11-16),

4. 10882837 - Amide compounds and use thereof (2021-01-05),

Title: Innovations of Cheng-Ho Chung

Introduction

Cheng-Ho Chung is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of chemistry, particularly in the development of amide compounds. With a total of 4 patents to his name, his work has garnered attention in both academic and pharmaceutical circles.

Latest Patents

Chung's latest patents include innovative processes for producing amide compounds and their crystalline and salt forms. One of these patents discloses a process characterized by an X-ray diffraction (XRD) pattern with specific peaks at about 14.2, 15.6, 16.4, 20.1, 20.5, and 21.2°±0.2° 2θ. Another notable patent involves compounds that can be used to reduce glycemic levels and treat glucagon-associated disorders, showcasing the potential therapeutic applications of his inventions.

Career Highlights

Cheng-Ho Chung is currently associated with Alphala Co., Ltd., where he continues to innovate and develop new chemical processes. His work has not only advanced the field of chemistry but has also contributed to the development of pharmaceutical solutions that can improve health outcomes.

Collaborations

Chung has collaborated with notable colleagues such as Shi-Liang Tseng and Yen-Fu Chen, further enhancing the impact of his research and inventions.

Conclusion

Cheng-Ho Chung's contributions to the field of chemistry through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new pharmaceutical compounds and processes.

Profile summary based on public USPTO records.